Syngene acquires first US biologics facility for $36.5 million
Overall investment in the US facility is estimated around US$50 million
Overall investment in the US facility is estimated around US$50 million
VITADEETM Green is a 100% plant-based Vitamin D3 suitable for food & nutraceuticals
Notably, 36 female students have been placed in Production and Manufacturing roles, reflecting the growing representation of women in core biotech operations
Eleven CRDMOs collaborate to form IPSO with the aim to elevate India’s position in the global pharmaceutical value-chain
The Formulation & Technology Centre intends to function as a technology storefront, offering advanced formulation and processing solutions to address the growing demand for complex drug formulations
Amgen India investment totals $200 million through 2025
Innovative chronic pain treatment receives IP protection in India's $55 billion pharmaceutical market
Peter Bains has over three decades of experience in the biotech and pharmaceutical industry
Wockhardt also saw its revenue from operations increased 3% to Rs. 721 crore during Q3 FY25
Subscribe To Our Newsletter & Stay Updated